| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 5.503 | 21.544 | 11.335 | 15.307 | 23.065 | 26.602 | 36.120 | 26.420 | 36.132 |
| Total Income - EUR | 0 | 5.503 | 21.544 | 11.335 | 15.318 | 24.399 | 26.602 | 36.120 | 26.420 | 36.132 |
| Total Expenses - EUR | 1.519 | 7.253 | 12.096 | 12.110 | 17.512 | 20.504 | 21.070 | 26.855 | 32.785 | 37.501 |
| Gross Profit/Loss - EUR | -1.519 | -1.750 | 9.448 | -775 | -2.194 | 3.895 | 5.532 | 9.265 | -6.364 | -1.368 |
| Net Profit/Loss - EUR | -1.519 | -1.915 | 8.801 | -1.101 | -2.347 | 3.664 | 5.266 | 8.962 | -6.583 | -1.775 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Plus Prime Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 888 | 879 | 864 | 848 | 832 | 816 | 798 | 800 | 798 | 2.018 |
| Current Assets | 11.944 | 12.911 | 21.641 | 12.670 | 12.071 | 3.477 | 5.911 | 6.140 | 9.067 | 1.831 |
| Inventories | 1.483 | 1.468 | 1.486 | 64 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.420 | 10.339 | 11.192 | 11.415 | 10.958 | 3.079 | 4.863 | 5.644 | 6.067 | 0 |
| Cash | 40 | 1.103 | 8.963 | 1.190 | 1.113 | 398 | 1.048 | 496 | 3.000 | 1.831 |
| Shareholders Funds | -56.823 | -58.159 | -48.374 | -48.587 | -49.993 | -54.176 | -47.709 | -38.895 | -45.360 | -46.881 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 69.687 | 71.980 | 70.909 | 62.134 | 62.896 | 58.469 | 54.417 | 45.835 | 55.224 | 50.730 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Plus Prime Intermed Srl